Coastal Investment Advisors, Inc. Cyma Bay Therapeutics, Inc. Transaction History

Coastal Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 05, 2020	SELL	$1.33 - $5.93 $1,064 - $4,744	-800 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$5.12 - $7.21 $13,312 - $18,746	-2,600 Reduced 76.47%	800 $4,000
Q2 2019 Aug 01, 2019	BUY	$6.05 - $13.66 $10,285 - $23,222	1,700 Added 100.0%	3,400 $24,000
Q1 2019 May 15, 2019	BUY	$8.16 - $13.42 $13,872 - $22,814	1,700 New	1,700 $22,000

1.88M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.